Target intelligence / Profile preview

JAK2, SRC, FAK

Molecular classification
Enzyme, Non-receptor tyrosine kinase
01

Overview

The input 'JAK2, SRC, FAK' refers to a grouping of three distinct, well-defined non-receptor tyrosine kinases: Janus kinase 2 (JAK2), Proto-oncogene tyrosine-protein kinase Src (SRC), and Focal adhesion kinase 1 (FAK). Each is an independent therapeutic target involved in critical cellular processes such as signal transduction, proliferation, adhesion, migration, and immune response. While distinct, they often participate in interconnected signaling pathways. This annotation aggregates information pertinent to all three given the query format, though detailed mechanisms and specific roles vary for each individual kinase.

Other names
JAK-2Janus kinase IITyrosine-protein kinase JAK2pp60c-srcc-SrcSrc kinasePTK2FAK1Protein tyrosine kinase 2 beta
02

Mechanism of action

These targets are distinct non-receptor tyrosine kinases whose individual inhibition impacts diverse cellular processes including proliferation, survival, adhesion, migration, and immune signaling, often relevant in cancer and inflammatory diseases. Specific mechanisms of action vary per kinase.

03

Biological functions

Signal transductionCell proliferationImmune responseHematopoiesisCell adhesionCell migrationCell survivalCytoskeletal organization
04

Disease associations

CancerInflammatory diseasesMyeloproliferative disordersInflammationFibrosis
05

Safety considerations

Cytopenias (anemia, neutropenia, thrombocytopenia)Increased infection riskThrombosisMyelosuppressionQT prolongation (with some inhibitors)Off-target effects due to homology with other kinasesImpaired wound healingPossible effects on normal cell adhesion and migration
06

Interacting drugs

9 more in the full profile.

07

Biomarkers

JAK2 V617F mutation (used in diagnosing myeloproliferative neoplasms)Increased Src phosphorylation/activity has prognostic significance in some cancers.Y397 phosphorylation (auto-phosphorylation site for FAK activation)

Beyond the preview

Go deeper on JAK2, SRC, FAK.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JAK2, SRC, FAK.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call